Previous 10 | Next 10 |
2023-11-15 17:25:24 ET Movano Inc. (MOVE) Q3 2023 Earnings Conference Call November 15, 2023 11:30 ET Company Participants Jay Cogan - Chief Financial Officer John Mastrototaro - Chief Executive Officer Tyler Bucher - Chief Marketing Officer Michael Leabman -...
2023-11-15 09:22:27 ET More on Movano Movano Health announces proposed public offering Financial information for Movano For further details see: Movano GAAP EPS of -$0.18
2023-11-15 06:48:12 ET More on Movano Movano Health announces proposed public offering Financial information for Movano For further details see: Movano Health prices $3.6 million public offering
Movano Health Provides Business Update and Reports Third Quarter 2023 Financial Results PR Newswire Conference call begins at 8:30 a.m. Pacific time today PLEASANTON, Calif. , Nov. 15, 2023 /PRNewswire/ -- Today, Movano Health (Nasdaq: MOVE), a pu...
Movano Health Prices $3.6 Million Public Offering PR Newswire PLEASANTON, Calif. , Nov. 15, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medtech and...
Movano Inc. to Report Third Quarter 2023 Financial Results on Wednesday, November 15, 2023 PR Newswire Reschedules Q3 results conference call to 11:30 am EST on November 15, 2023 PLEASANTON, Calif. , Nov. 14, 2023 /PRNewswire/ -- Movano Inc. ...
2023-11-14 16:10:46 ET More on Movano Financial information for Movano For further details see: Movano Health announces proposed public offering
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Movano Inc. to Report Third Quarter 2023 Financial Results Tuesday, November 14, 2023 PR Newswire PLEASANTON, Calif. , Nov. 3, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection ...
Movano Health's Proprietary Chip and Prototype Achieves Accuracy Commensurate with the FDA's Requirements for Blood Pressure Monitoring PR Newswire Leveraging the Company's 4 x 6.7 mm System-on-a-Chip (SoC), the clinical study results are a significant step forward in commerci...
News, Short Squeeze, Breakout and More Instantly...
Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event PR Newswire Allele Capitals' Matt Hughes will moderate future forward panel on enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif. , June 28, 2...
Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion PR Newswire Enhancements address significant clinical enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif. , June 13, 20...
MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease PR Newswire Pioneering partnership advances innovative health monitoring, setting the stage for future enterprise opportunities. PLEASANTON, Calif. , June 10, 2024 ...